DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Papadimitrakopoulou VA, Cobo M, Bordoni R, Dubray-Longeras P, Szalai Z, Ursol G. et al.
Impower132: PFS and safety results with 1L atezolizumab + carboplatin/cisplatin + pemetrexed in stage IV non-squamous NSCLC. 2018 World Conference on Lung Cancer. Abstract OA05.07. Presented September 24, 2018.
We do not assume any responsibility for the contents of the web pages of other providers.